Mallinckrodt reports $10.7 million paid on $1.94 billion of allowed unsecured claims; unsecured claims trust extended to 2030
ElevenFlo ·
Mallinckrodt’s plan took effect on June 16, 2022 Dkt. 7652, and the case is now in post-confirmation claims administration. The reorganized debtor’s report for the quarter ended September 30, 2026 lists $10,650,614 paid on $1,940,145,874 of allowed general unsecured claims Dkt. 9415. Next come the January 29, 2027 fact-discovery deadline in the opioid trust’s Covidien spinoff suit Dkt. 9418 and March 29, 2027, the extended deadline to object to administrative claims Dkt. 9410.
Jump to section
The specialty biopharmaceutical company emerged from chapter 11 on June 16, 2022. Claims administration continues, and the Opioid Master Disbursement Trust II is suing Covidien over the 2013 spinoff, with fact discovery due January 29, 2027.
Mallinckrodt plc’s chapter 11 plan took effect on June 16, 2022, when the company filed notice of the plan’s effectiveness Dkt. 7652. A final decree entered on May 3, 2023 closed certain of the affiliated debtors’ cases Dkt. 8760. The lead case, filed October 12, 2020, remains open for claims administration and for periodic reports from the reorganized debtor and the post-emergence trusts.
The reorganized debtor’s post-confirmation report for the quarter ended September 30, 2026 shows $3,114,917 disbursed in the quarter and $252,256,884 since the effective date Dkt. 9415. It reports administrative, secured and priority claims paid at 100% of their allowed amounts. Allowed general unsecured claims total $1,940,145,874, and $10,650,614 has been paid on them, which the report lists as 1%. The report shows no payment on equity interests.
| Claims | Paid under the plan | Share of allowed claims paid |
|---|---|---|
| Administrative claims | $81,063,532 | 100% |
| Secured claims | $111,049 | 100% |
| Priority claims | $145,145 | 100% |
| General unsecured claims ($1,940,145,874 allowed) | $10,650,614 | 1% |
| Equity interests | None |
On October 13, 2026, the court extended the reorganized debtor’s deadline to object to administrative claims by 182 days, through March 29, 2027 Dkt. 9410. The same day, it extended the termination date of the Mallinckrodt General Unsecured Claims Trust, whose trustee is Heather L. Barlow, through June 16, 2030 Dkt. 9409. The trustee’s agenda reported no objections to that motion by the October 8 deadline, so the October 15 hearing was not needed Dkt. 9411.
The claims agent’s register for the third quarter of 2026 still carries large filed amounts. They include $1 billion claims by plaintiff states against Mallinckrodt plc and Mallinckrodt LLC, and a $322,868,000 secured claim against Mallinckrodt plc. The register reports current claim amounts and does not establish allowance or payment Dkt. 9417. Separately, on September 30, 2026, the court told the parties that a hearing Mr. Dudley had requested on certain pleadings could not go forward on October 7. It asked them to confer and get a new date Dkt. 9401.
The opioid trust’s suit over the 2013 Covidien spinoff is the main open litigation
The Opioid Master Disbursement Trust II’s report for June 1 through September 30, 2026 says the trust began the period with $91,274,822 in cash. It received $1,057,107 in interest and other income, paid $3,500,091 in expenses and ended with $88,831,838, all held in short-term U.S. government obligations Dkt. 9418. Legal and litigation support accounted for $2,916,559 of those expenses.
In the Covidien spinoff action, the trust seeks recovery or avoidance relating to the 2013 spinoff. Its claims include approximately $867 million in net cash transfers and approximately $721 million in note proceeds, along with other obligations and opioid-related costs. The court denied Covidien’s summary judgment motion except as to Count I against Covidien S.à r.l., which remains a defendant on the other counts. Document discovery closed on September 30, 2026 with disputes outstanding, and fact discovery is due January 29, 2027 Dkt. 9418.
The trust’s other actions have narrowed. In the insurance action, the Missouri Court of Appeals affirmed summary judgment for the insurers on July 21, 2026, and the Missouri Supreme Court denied transfer on September 29, 2026. The parties were discussing a new schedule for the policies still in the litigation. The share repurchase action sought to recover part of the more than $1 billion paid to equity holders from 2015 to 2018. The court closed it on August 13, 2026, after the trust dismissed the remaining John Doe defendants Dkt. 9418.
The deadline to object to other opioid claims is the later of March 15, 2027 or 120 days after a claim is amended in writing by or for its holder. The trustees do not expect the remaining claims to materially affect trust assets. The trust budgets $11,955,341 in expenses for June 2026 through May 2027, including $10,652,759 for legal and litigation support, and forecasts ending cash of $82,518,803 Dkt. 9418. A separate trust, the Mallinckrodt Opioid Personal Injury Trust, filed its 2025 annual report on October 2, 2026, after receiving its outside audit report Dkt. 9405.
Opioid and Acthar litigation drove the 2020 filing
Mallinckrodt is a specialty biopharmaceutical company headquartered in Dublin, Ireland. Its Specialty Brands segment focuses on autoimmune and rare diseases, and its Specialty Generics segment makes controlled substances and active pharmaceutical ingredients. Covidien spun the company off in 2013. In fiscal 2019, Acthar led Specialty Brands revenue at $952.7 million, followed by INOmax at $571.4 million Dkt. 128.
The company filed on October 12, 2020, facing more than 3,000 opioid-related lawsuits and litigation over Acthar. Its first-day declaration said it had spent more than $100 million on defense since 2017 and was spending more than $1 million a week on litigation. The declaration described a proposed $1.6 billion opioid settlement, supported by more than 40 attorneys general, as a cornerstone of the restructuring. It also described a $260 million settlement with the Department of Justice that resolves most Acthar-related government claims Dkt. 128. The company filed with a restructuring support agreement signed by 84% of unsecured noteholders and by representatives of more than 1,000 opioid plaintiffs. The agreement included reinstating the secured debt and issuing new second lien notes and equity Dkt. 128.
Funded debt was $5.283 billion, about $3.62 billion of it secured
The first-day declaration reported funded debt of approximately $5.283 billion at the petition date Dkt. 128 · p. 22. A later debtors’ motion put the secured portion at approximately $3.62 billion Dkt. 7105 · p. 4. The secured debt was owed by two finance subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC. It consisted of a $900 million revolver maturing in February 2022, term loans due 2024 and 2025 and 10.000% first lien notes due 2025, all with first-priority liens, plus $322.9 million of 10.000% second lien notes due 2025. Four series of senior unsecured notes and two small legacy debenture issues at Ludlow LLC made up the rest.
- First lien
- Second lien
- Unsecured notes
- Legacy debentures
- Revolving credit facility due February 2022Mallinckrodt CB LLC$900.0M
- Term loan due September 2024Mallinckrodt International Finance S.A.$1,505.2M
- Term loan due February 2025Mallinckrodt International Finance S.A.$399.5M
- 10.000% first lien senior secured notes due April 2025Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC$495.0M
- 10.000% second lien senior secured notes due April 2025Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC$322.9M
- 5.75% senior notes due August 2022Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC$610.3M
- 5.625% senior notes due October 2023Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC$514.7M
- 5.500% senior notes due April 2025Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC$387.2M
- 4.750% senior notes due April 2023Mallinckrodt International Finance S.A., guaranteed by Mallinckrodt plc$133.7M
- 9.50% debentures due May 2022Ludlow LLC$10.4M
- 8.00% debentures due March 2023Ludlow LLC$4.45M
Total (approximate, as reported)$5,283.0M
Show the numbers
| Debt | Borrower or issuer | Principal |
|---|---|---|
| Revolving credit facility due February 2022 | Mallinckrodt CB LLC | $900.0M |
| Term loan due September 2024 | Mallinckrodt International Finance S.A. | $1,505.2M |
| Term loan due February 2025 | Mallinckrodt International Finance S.A. | $399.5M |
| 10.000% first lien senior secured notes due April 2025 | Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC | $495.0M |
| 10.000% second lien senior secured notes due April 2025 | Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC | $322.9M |
| 5.75% senior notes due August 2022 | Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC | $610.3M |
| 5.625% senior notes due October 2023 | Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC | $514.7M |
| 5.500% senior notes due April 2025 | Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC | $387.2M |
| 4.750% senior notes due April 2023 | Mallinckrodt International Finance S.A., guaranteed by Mallinckrodt plc | $133.7M |
| 9.50% debentures due May 2022 | Ludlow LLC | $10.4M |
| 8.00% debentures due March 2023 | Ludlow LLC | $4.45M |
| Total (approximate, as reported) | $5,283.0M |
Source: first-day declaration Dkt. 128 · p. 22
Two exchanges before the filing converted unsecured notes into secured notes. The creditors’ committee described a December 2019 exchange of five tranches of senior unsecured notes, with maturities from 2020 to 2025 and coupons from 4.75% to 5.75%, for 10% second lien notes due 2025. It also described an April 2020 exchange of $495 million of 4.875% unsecured notes due 2020 for $495 million of 10% first lien notes due 2025 Dkt. 1632 · p. 9. In March 2021 the committee sought Rule 2004 discovery and more time to challenge the debtors’ stipulations in the final cash collateral order Dkt. 1632. On April 13, 2021, the court extended the challenge period by order and denied the committee’s extension request as moot Dkt. 2022. A stipulation approved May 26, 2021 set limited challenge deadlines of June 6, 2021 for the opioid claimants’ committee and July 2, 2021 for the unsecured creditors’ committee, with matching intervention deadlines for the future claimants’ representative Dkt. 2576. The court approved a further extension on September 23, 2021 Dkt. 4463.
The case ran on consensual use of cash collateral
The debtors funded the case with the prepetition secured parties’ cash collateral. The court authorized its use on an interim basis on October 14, 2020 Dkt. 213. The Multi-State Governmental Entities Group withdrew its limited objection Dkt. 507, and the final cash collateral order followed on November 20, 2020 Dkt. 586. The debtors’ motion proposed milestones requiring a plan and disclosure statement within 12 months of the petition date and confirmation within 18 months Dkt. 103.
The court modified the arrangement as the case went on. It entered a modification order on February 2, 2021 Dkt. 1263. On March 16, 2021, it authorized use of cash collateral outside the ordinary course Dkt. 1745, relief the ad hoc first lien term lender group supported Dkt. 1707. On April 13, 2021, it reset the term lenders’ adequate-protection payments, effective from the date of the motion, for as long as the term lenders’ joinder and amendment to the restructuring support agreement stayed in force Dkt. 2021. As confirmation moved into 2022, the court extended the outside termination date from April 30 to May 30, 2022 Dkt. 7226 and then by another 21 days Dkt. 7500. Use of cash collateral ended at emergence on June 16, 2022.
The plan went through four amended versions before approval in June 2022
The debtors filed their plan Dkt. 2074 and disclosure statement Dkt. 2075 on April 20, 2021, and the solicitation version of the disclosure statement on June 18, 2021 Dkt. 2917. Amended plans followed on September 29, 2021 Dkt. 4508, December 2, 2021 Dkt. 5636, December 29, 2021 Dkt. 6006 and January 6, 2022 Dkt. 6066. The debtors filed technical modifications on February 18, 2022 Dkt. 6510. On June 7, 2022, the court approved the opioid deferred cash payments agreement and a guarantee agreement and incorporated both into the confirmation order Dkt. 7598. The modified fourth amended plan, in the form the court approved on June 8, 2022, was filed on June 21, 2022 Dkt. 7670.
The confirmed plan allowed revolver claims at $900 million, less any principal payments designated as such, plus accrued interest and other first lien obligations Dkt. 7670 · p. 61. It allowed first lien notes claims at $495,032,000 plus accrued interest, premiums, fees and costs Dkt. 7670 · p. 64. Its second lien notes term sheet sets the amount at $322,868,000, the outstanding principal of the existing second lien notes Dkt. 7670 · p. 178. The December 2021 version of that term sheet kept the existing notes’ issuers, 10.00% cash coupon and April 15, 2025 maturity Dkt. 6006 · p. 178. The term loans had been reduced during the case. The June 2021 plan put their outstanding principal at $1,407,557,343.72 for the 2024 loan and $373,591,066.61 for the 2025 loan as of April 23, 2021 Dkt. 2767, compared with $1,505,211,683.76 and $399,488,946.81 at the petition date. The fourth amended plan allowed the guaranteed unsecured notes claims at not less than principal plus accrued prepetition interest Dkt. 6066 · p. 65.
During the case, the court also approved a sale of certain VTESSE LLC assets on June 29, 2021 Dkt. 3070. After emergence, an appeal in the district court (BAP No. 21-1155) was voluntarily dismissed by stipulation, docketed February 17, 2023 Dkt. 8556.
Sources
- Dkt. 103Motion to Approve Use of Cash Collateral (Motion of the Debtors for Interim and Final Orders Under Bankruptcy Code Sections 105(a), 361, 362, 363, 503, and 507, and Bankruptcy Rules 4001 and 9014 (I) Authorizing Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Secured Parties; (III) Modifying the Automatic Stay; and (IV) Granting Related Relief ) Filed By Mallinckrodt plc (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C)Filed Oct 12, 2020Oct 12, 2020
- Dkt. 128First Day DeclarationCited at p. 22 · Filed Oct 12, 2020Oct 12, 2020
- Dkt. 213Order (INTERIM) (I) Authorizing Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Secured Parties; (III) Modifying the Automatic Stay; and (IV) Granting Related Relief (Related Document(s) 103) Order Signed on 10/14/2020. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2)Filed Oct 14, 2020Oct 14, 2020
- Dkt. 507Notice of Withdrawal of the Multi-State Governmental Entities Group's Limited Objection to Debtors' Motion to Use Cash Collateral (related document(s)396) Filed by Multi-State Governmental Entities Group.Filed Nov 15, 2020Nov 15, 2020
- Dkt. 586Final Order Under Bankruptcy Code Sections 105(a), 361, 362, 363, 503, and 507, and Bankruptcy Rules 4001 and 9014 (I) Authorizing Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Secured Parties; (III) Modifying the Automatic Stay; and (IV) Granting Related Relief (related document(s)103) Order Signed on 11/20/2020. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3)Filed Nov 20, 2020Nov 20, 2020
- Dkt. 1263Order Modifying Cash Collateral Order (Related Doc # 1209, 586, 1262) Order Signed on 2/2/2021.Filed Feb 2, 2021Feb 2, 2021
- Dkt. 1632Motion for 2004 Examination Motion of the Official Committee of Unsecured Creditors (1) For an Order Pursuant to Bankruptcy Rule 2004 Authorizing Discovery of the Debtors and Third Parties, and (2) For an Order Extending Period to (A) Challenge the Debtors' Stipulations as Set Forth in the Final Cash Collateral Order and (B) Assert Related Claims or Causes of Action Filed by Official Committee of Unsecured Creditors Mallinckrodt plc. Objections due by 3/23/2021. (Attachments: # 1 Notice # 2 Proposed Form of Order # 3 Certificate of Service)Cited at p. 9 · Filed Mar 10, 2021Mar 10, 2021
- Dkt. 1707Motion for Leave (Motion of the Ad Hoc First Lien Term Lender Group for Leave to File a Reply in Support of Debtors' Motion for Order (I) Authorizing Use of Cash Collateral Other Than in the Ordinary Course of Business, (II) Granting Limited Relief from the Automatic Stay, and (III) Granting Related Relief) (related document(s)1704) Filed by Ad Hoc First Lien Term Lender Group. Hearing scheduled for 3/16/2021 at 11:00 AM at US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #5, Wilmington, Delaware. (Attachments: # 1 Exhibit A - Proposed Order)Filed Mar 15, 2021Mar 15, 2021
- Dkt. 1745Order Granting Motion for Order (I) Authorizing Use of Cash Collateral Other Than in the Ordinary Course of Business, (II) Granting Limited Relief from the Automatic Stay, and (III) Granting Related Relief (Related Doc # 1441, 1663, 1684, 1700, 1734) Order Signed on 3/16/2021.Filed Mar 16, 2021Mar 16, 2021
- Dkt. 2021Order (I) Modifying Cash Collateral Order with Respect to Adequate Protection Terms, (II) Permitting the Debtors to Pay Certain Amounts, and (III) Granting Related Relief (Related Doc # 1824, 1969, 2019) Order Signed on 4/13/2021.Filed Apr 13, 2021Apr 13, 2021
- Dkt. 2022Order (I) Extending the Challenge Period Termination Date Set Forth in the Final Cash Collateral Order and (II) Denying the Official Committee of Unsecured Creditors' Motion to Extend the Challenge Period Termination Date as Moot (Related Doc # 586, 1632) Order Signed on 4/13/2021.Filed Apr 13, 2021Apr 13, 2021
- Dkt. 2074Chapter 11 Plan of Reorganization (Joint Plan of Reorganization of Mallinckrodt plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code) Filed by Mallinckrodt plcFiled Apr 20, 2021Apr 20, 2021
- Dkt. 2075Disclosure Statement for Joint Chapter 11 Plan of Reorganization of Mallinckrodt plc and Its Debtors Affiliates Under Chapter 11 of the Bankruptcy Code (related document(s)2074) Filed by Mallinckrodt plcFiled Apr 20, 2021Apr 20, 2021
- Dkt. 2576Order Approving Stipulation Extending the Challenge Period Termination Date Set Forth in the Final Cash Collateral Order (Related Document(s) 2571) Order Signed on 5/26/2021. (Attachments: # 1 Exhibit 1)Filed May 26, 2021May 26, 2021
- Dkt. 2767Chapter 11 Plan of Reorganization (Joint Plan of Reorganization of Mallinckrodt plc and its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code) Filed by Mallinckrodt plcFiled Jun 8, 2021Jun 8, 2021
- Dkt. 2917Disclosure Statement for Joint Chapter 11 Plan of Reorganization of Mallinckrodt plc and its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code - Solicitation Version (related document(s)2916) Filed by Mallinckrodt plcFiled Jun 18, 2021Jun 18, 2021
- Dkt. 3070Order Pursuant to 11 U.S.C. §§ 105(a), 363, and 365, Federal Rules of Bankruptcy Procedure 2002, 6004, 6006, 9007, 9008 and 9014 and Local Rule 6004-1 (I) Approving the Sale of Certain VTESSE LLC Assets; (II) Approving the Assumption and Assignment of Executory Contracts and Unexpired Leases; (III) Authorizing Consummation of the Sale Transaction; and (IV) Granting Related Relief (Related Doc # 2433) Order Signed on 6/29/2021. (Attachments: # 1 Exhibit A # 2 Exhibit B)Filed Jun 29, 2021Jun 29, 2021
- Dkt. 4463Order Approving Stipulation Extending the Challenge Period Termination Date in the Final Cash Collateral Order (related document(s)586, 2022, 2576, 4448) Order Signed on 9/23/2021. (Attachments: # 1 Exhibit 1)Filed Sep 23, 2021Sep 23, 2021
- Dkt. 4508Amended Chapter 11 Plan (First Amended Joint Plan of Reorganization of Mallinckrodt plc and its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code) (related document(s)2916) Filed by Mallinckrodt plcFiled Sep 29, 2021Sep 29, 2021
- Dkt. 5636Joint Amended Chapter 11 Plan // Second Amended Joint Plan of Reorganization of Mallinckrodt PLC and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (related document(s)2074, 2767, 2903, 2916, 4508) Filed by Mallinckrodt plcFiled Dec 2, 2021Dec 2, 2021
- Dkt. 6006Joint Amended Chapter 11 Plan // Third Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (related document(s)5636) Filed by Mallinckrodt plcCited at p. 178 · Filed Dec 29, 2021Dec 29, 2021
- Dkt. 6066Joint Amended Chapter 11 Plan // Fourth Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (related document(s)6006) Filed by Mallinckrodt plc (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3 # 4 Exhibit 4 # 5 Exhibit 5 # 6 Exhibit 6 # 7 Exhibit 7)Cited at p. 65 · Filed Jan 6, 2022Jan 6, 2022
- Dkt. 6510Amended Chapter 11 Plan // Fourth Amended Joint Plan of Reorganization (With Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (related document(s)6066) Filed by Mallinckrodt plc (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3 # 4 Exhibit 4 # 5 Exhibit 5 # 6 Exhibit 6 # 7 Exhibit 7)Filed Feb 18, 2022Feb 18, 2022
- Dkt. 7105Motion to Extend (Motion of the Debtors for Entry of Order Extending Outside Termination Date Under Cash Collateral Order by 30 Days and Granting Related Relief) Filed by Mallinckrodt plc. Hearing scheduled for 4/25/2022 at 03:00 PM at US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #5, Wilmington, Delaware. Objections due by 4/22/2022. (Attachments: # 1 Notice of Motions and Hearing # 2 Exhibit A)Cited at p. 4 · Filed Apr 15, 2022Apr 15, 2022
- Dkt. 7226Order Extending Outside Termination Date Under Cash Collateral Order by 30 Days and Granting Related Relief (Related Document(s) 7105, 7225) Order Signed on 4/24/2022.Filed Apr 24, 2022Apr 24, 2022
- Dkt. 7500Order Further Extending Outside Termination Date Under Cash Collateral Order by 21 Days and Granting Related Relief (Related Document(s) 103, 586, 7226, 7488) Order Signed on 5/25/2022.Filed May 25, 2022May 25, 2022
- Dkt. 7598Order (A) Approving and So-Ordering the Opioid Deferred Cash Payments Agreement and Incorporating It Into the Confirmation Order, (B) Approving and So-Ordering the Guarantee Agreement and Incorporating It Into the Confirmation Order, and (C) Granting Related Relief (Related Doc # 7534, 7572, 7596, 7597) Order Signed on 6/7/2022. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2)Filed Jun 7, 2022Jun 7, 2022
- Dkt. 7652Notice of Effective Date // Notice of Occurrence of Effective Date of Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code Filed by Mallinckrodt plc.Filed Jun 16, 2022Jun 16, 2022
- Dkt. 7670Chapter 11 Plan of Reorganization //Modified Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (as approved by the Court on 6/8/22 (D.I. 7602)) Filed by Mallinckrodt plcFiled Jun 21, 2022Jun 21, 2022
- Dkt. 8556COPY OF STIPULATED VOLUNTARY DISMISSAL from District Court BAP #21-1155 Order (related document(s)3641) Order Signed on 2/17/2023.Filed Feb 17, 2023Feb 17, 2023
- Dkt. 8760Order and Final Decree Closing Certain Chapter 11 Cases in Connection with Reorganized Debtors' Plan of Reorganization (related document(s)(8658(, 8758) Order Signed on 5/3/2023. (Attachments: # 1 Schedule 1)Filed May 3, 2023May 3, 2023
- Dkt. 9401Hearing Date RequestFiled Sep 30, 2026Sep 30, 2026
- Dkt. 9405Trust 2025 Annual ReportFiled Oct 2, 2026Oct 2, 2026
- Dkt. 9409GUC Trust ExtensionFiled Oct 13, 2026Oct 13, 2026
- Dkt. 9410Administrative Claims Deadline ExtensionFiled Oct 13, 2026Oct 13, 2026
- Dkt. 9411Trust Termination Extension AgendaFiled Oct 13, 2026Oct 13, 2026
- Dkt. 9415Quarterly Post-Confirmation ReportFiled Oct 21, 2026Oct 21, 2026
- Dkt. 9417Q3 2026 Claim RegistersFiled Oct 26, 2026Oct 26, 2026
- Dkt. 9418Opioid Trust Periodic ReportFiled Oct 30, 2026Oct 30, 2026